• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy.在接受达比加群治疗的非透析治疗的慢性肾脏病全谱患者中发生大出血的危险因素。
Am J Kidney Dis. 2021 Jul;78(1):151-153. doi: 10.1053/j.ajkd.2020.09.018. Epub 2020 Dec 2.
2
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.影响心房颤动合并慢性肾脏病患者达比加群谷浓度的因素
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):151-156. doi: 10.1007/s40292-020-00373-2. Epub 2020 Mar 25.
3
Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation.在服用达比加群治疗心房颤动的患者中，他汀类药物使用与缺血性卒中或大出血之间的关联。
CMAJ. 2017 Jan 9;189(1):E4-E10. doi: 10.1503/cmaj.160303. Epub 2016 Nov 21.
4
Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure.两名严重肾衰竭患者使用艾达赛珠单抗逆转后达比加群水平的晚期反弹。
Eur J Anaesthesiol. 2017 Jun;34(6):400-402. doi: 10.1097/EJA.0000000000000617.
5
Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review.血液透析治疗达比加群相关出血：病例报告及系统评价。
J Thromb Haemost. 2015 Oct;13(10):1790-8. doi: 10.1111/jth.13117. Epub 2015 Sep 29.
6
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study.新型口服抗凝剂与老年慢性肾脏病患者大出血风险：一项巢式病例对照研究。
Can J Cardiol. 2016 Aug;32(8):986.e17-22. doi: 10.1016/j.cjca.2016.01.013. Epub 2016 Jan 22.
7
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.老年肾小球滤过率降低患者接受直接口服抗凝剂的心血管事件和死亡率风险。
Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22.
8
Idarucizumab for dabigatran reversal: the first 6 months in a tertiary centre.达比加群酯逆转剂idarucizumab：在一家三级中心的头 6 个月。
Intern Med J. 2019 Oct;49(10):1316-1320. doi: 10.1111/imj.14459.
9
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.达比加群相关危及生命出血患者管理的综述与建议：单中心大学医院经验
J Intensive Care Med. 2015 Dec;30(8):462-72. doi: 10.1177/0885066614527417. Epub 2014 Mar 25.
10
Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.使用依达赛珠单抗逆转急性肾损伤出血患者的达比加群效应。
Thromb Haemost. 2017 Jan 5;117(1):196-197. doi: 10.1160/TH16-06-0445. Epub 2016 Oct 13.

引用本文的文献

1
Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics.为多样化人群制定直接口服抗凝剂治疗方案：种族、肾功能、药物相互作用和药物基因组学的作用。
Clin Pharmacol Ther. 2023 Mar;113(3):585-599. doi: 10.1002/cpt.2714. Epub 2022 Aug 4.

本文引用的文献

1
Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.2019 年慢性肾脏病患者人群中预防房颤血栓栓塞的口服抗凝治疗：现状。
Cardiovasc Drugs Ther. 2019 Aug;33(4):481-488. doi: 10.1007/s10557-019-06885-x.
2
Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.指南指导下的房颤卒中预防治疗是可以实现的。
Circulation. 2019 Mar 19;139(12):1497-1506. doi: 10.1161/CIRCULATIONAHA.118.035909.
3
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病与心律失常：来自改善全球肾脏病预后组织（KDIGO）争议会议的结论
Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060.
4
Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.肾功能对华法林使用者国际标准化比值超治疗范围相关出血风险的影响：一项前瞻性队列研究。
Am J Kidney Dis. 2015 May;65(5):701-9. doi: 10.1053/j.ajkd.2014.11.004. Epub 2014 Nov 25.
5
Influence of kidney function on risk of hemorrhage among patients taking warfarin: a cohort study.肾功能对华法林治疗患者出血风险的影响：一项队列研究。
Am J Kidney Dis. 2013 Feb;61(2):354-7. doi: 10.1053/j.ajkd.2012.09.012. Epub 2012 Nov 16.
6
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.使用慢性肾脏病流行病学协作组（CKD-EPI）肌酐方程估算肾小球滤过率（GFR）：GFR估算更准确，慢性肾脏病患病率估算更低，风险预测更优。
Am J Kidney Dis. 2010 Apr;55(4):622-7. doi: 10.1053/j.ajkd.2010.02.337.
7
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.非手术患者抗止血药品临床研究中严重出血的定义。
J Thromb Haemost. 2005 Apr;3(4):692-4. doi: 10.1111/j.1538-7836.2005.01204.x.

Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy.

作者信息

Davis Brittney H, Sangha Rajbeer, Dillon Chrisly, Brown Todd M, Narayan Renuka, Beasley Mark, McElderry Tom, Nolin Thomas D, Limdi Nita A

机构信息

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL.

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL.

出版信息

Am J Kidney Dis. 2021 Jul;78(1):151-153. doi: 10.1053/j.ajkd.2020.09.018. Epub 2020 Dec 2.

DOI:10.1053/j.ajkd.2020.09.018
PMID:33276038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546791/
Abstract
摘要